Log in to save to my catalogue

NF-[kappa]B is activated in response to temozolomide in an AKT-dependent manner and confers protecti...

NF-[kappa]B is activated in response to temozolomide in an AKT-dependent manner and confers protecti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1271959254

NF-[kappa]B is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug

About this item

Full title

NF-[kappa]B is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug

Publisher

London: BioMed Central

Journal title

Journal of translational medicine, 2012-01, Vol.10

Language

English

Formats

Publication information

Publisher

London: BioMed Central

More information

Scope and Contents

Contents

Doc number: 252 Abstract Background: Most DNA-damaging chemotherapeutic agents activate the transcription factor nuclear factor κB (NF-κB). However, NF-κB activation can either protect from or contribute to the growth suppressive effects of the agent. We previously showed that the DNA-methylating drug temozolomide (TMZ) activates AKT, a positive mo...

Alternative Titles

Full title

NF-[kappa]B is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1271959254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1271959254

Other Identifiers

E-ISSN

1479-5876

DOI

10.1186/1479-5876-10-252

How to access this item